198 related articles for article (PubMed ID: 11024046)
21. Binding of human alpha-thrombin to platelet GpIb: energetics and functional effects.
de Cristofaro R; de Candia E; Croce G; Morosetti R; Landolfi R
Biochem J; 1998 Jun; 332 ( Pt 3)(Pt 3):643-50. PubMed ID: 9620865
[TBL] [Abstract][Full Text] [Related]
22. Heparin enhances the catalytic activity of des-ETW-thrombin.
Goodwin CA; Deadman JJ; Le Bonniec BF; Elgendy S; Kakkar VV; Scully MF
Biochem J; 1996 Apr; 315 ( Pt 1)(Pt 1):77-83. PubMed ID: 8670135
[TBL] [Abstract][Full Text] [Related]
23. Allosteric changes in thrombin's activity produced by peptides corresponding to segments of natural inhibitors and substrates.
Hortin GL; Trimpe BL
J Biol Chem; 1991 Apr; 266(11):6866-71. PubMed ID: 1849894
[TBL] [Abstract][Full Text] [Related]
24. Binding of thrombin to the G-protein-linked receptor, and not to glycoprotein Ib, precedes thrombin-mediated platelet activation.
Liu L; Freedman J; Hornstein A; Fenton JW; Song Y; Ofosu FA
J Biol Chem; 1997 Jan; 272(3):1997-2004. PubMed ID: 8999892
[TBL] [Abstract][Full Text] [Related]
25. Structures of thrombin complexes with a designed and a natural exosite peptide inhibitor.
Qiu X; Yin M; Padmanabhan KP; Krstenansky JL; Tulinsky A
J Biol Chem; 1993 Sep; 268(27):20318-26. PubMed ID: 8376390
[TBL] [Abstract][Full Text] [Related]
26. Molecular mapping of the heparin-binding exosite of thrombin.
Sheehan JP; Sadler JE
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5518-22. PubMed ID: 8202520
[TBL] [Abstract][Full Text] [Related]
27. The isomorphous structures of prethrombin2, hirugen-, and PPACK-thrombin: changes accompanying activation and exosite binding to thrombin.
Vijayalakshmi J; Padmanabhan KP; Mann KG; Tulinsky A
Protein Sci; 1994 Dec; 3(12):2254-71. PubMed ID: 7756983
[TBL] [Abstract][Full Text] [Related]
28. Release of fibrinopeptides by the slow and fast forms of thrombin.
Vindigni A; Di Cera E
Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
[TBL] [Abstract][Full Text] [Related]
29. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin.
Ward CM; Andrews RK; Smith AI; Berndt MC
Biochemistry; 1996 Apr; 35(15):4929-38. PubMed ID: 8664285
[TBL] [Abstract][Full Text] [Related]
30. The platelet high affinity binding site for thrombin mimics hirudin, modulates thrombin-induced platelet activation, and is distinct from the glycoprotein Ib-IX-V complex.
Hayes KL; Tracy PB
J Biol Chem; 1999 Jan; 274(2):972-80. PubMed ID: 9873039
[TBL] [Abstract][Full Text] [Related]
31. Thrombin-induced platelet activation is inhibited by high- and low-molecular-weight heparin.
De Candia E; De Cristofaro R; Landolfi R
Circulation; 1999 Jun; 99(25):3308-14. PubMed ID: 10385507
[TBL] [Abstract][Full Text] [Related]
32. Proteolytic formation of either of the two prothrombin activation intermediates results in formation of a hirugen-binding site.
Liu LW; Ye J; Johnson AE; Esmon CT
J Biol Chem; 1991 Dec; 266(35):23633-6. PubMed ID: 1748641
[TBL] [Abstract][Full Text] [Related]
33. Role of glycoprotein V in the formation of the platelet high-affinity thrombin-binding site.
Dong JF; Sae-Tung G; López JA
Blood; 1997 Jun; 89(12):4355-63. PubMed ID: 9192758
[TBL] [Abstract][Full Text] [Related]
34. Bothrojaracin: a potent two-site-directed thrombin inhibitor.
Arocas V; Zingali RB; Guillin MC; Bon C; Jandrot-Perrus M
Biochemistry; 1996 Jul; 35(28):9083-9. PubMed ID: 8703912
[TBL] [Abstract][Full Text] [Related]
35. Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of Par-1 on intact platelets.
De Candia E; Hall SW; Rutella S; Landolfi R; Andrews RK; De Cristofaro R
J Biol Chem; 2001 Feb; 276(7):4692-8. PubMed ID: 11084032
[TBL] [Abstract][Full Text] [Related]
36. Binding of exosite ligands to human thrombin. Re-evaluation of allosteric linkage between thrombin exosites I and II.
Verhamme IM; Olson ST; Tollefsen DM; Bock PE
J Biol Chem; 2002 Mar; 277(9):6788-98. PubMed ID: 11724802
[TBL] [Abstract][Full Text] [Related]
37. Thrombin interaction with platelet GpIb: structural mapping and effects on platelet activation (review).
De Cristofaro R; De Candia E
Int J Mol Med; 1999 Apr; 3(4):363-71. PubMed ID: 10085407
[TBL] [Abstract][Full Text] [Related]
38. Thrombin-specific inhibition by and slow cleavage of hirulog-1.
Witting JI; Bourdon P; Brezniak DV; Maraganore JM; Fenton JW
Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):737-43. PubMed ID: 1290488
[TBL] [Abstract][Full Text] [Related]
39. The fibrinogen anion-binding exosite of thrombin is necessary for induction of rises in intracellular calcium and prostacyclin production in endothelial cells.
Ngaiza JR; Manley G; Grulich-Henn J; Krstenansky JL; Jaffe EA
J Cell Physiol; 1992 Apr; 151(1):190-6. PubMed ID: 1560043
[TBL] [Abstract][Full Text] [Related]
40. Kinetic mechanism for the interaction of Hirulog with thrombin.
Parry MA; Maraganore JM; Stone SR
Biochemistry; 1994 Dec; 33(49):14807-14. PubMed ID: 7993908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
